Acadia Pharmaceuticals

502 articles with Acadia Pharmaceuticals

• ACADIA Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

  5/13/2008

• ACADIA Pharmaceuticals, Inc. Reports First Quarter 2008 Financial Results

  5/6/2008

• ACADIA Pharmaceuticals, Inc. Announces Election of Laura A. Brege to Board of Directors

  5/5/2008

• ACADIA Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

  4/30/2008

• ACADIA Pharmaceuticals, Inc. to Announce First Quarter 2008 Financial Results on May 5, 2008

  4/28/2008

• ACADIA Pharmaceuticals, Inc. to Present Data from Its Phase II Trial with Pimavanserin for Parkinson's Disease Psychosis at the 60th American Academy of Neurology Annual Meeting

  4/16/2008

• ACADIA Pharmaceuticals, Inc. to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting

  4/4/2008

• ACADIA Pharmaceuticals, Inc. Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis

  3/31/2008

• ACADIA Pharmaceuticals, Inc. to Present at the 8th Annual Fortis Bank Biotechnology Conference

  3/28/2008

• ACADIA Pharmaceuticals, Inc. to Present at Lehman Brothers 11th Annual Global Healthcare Conference

  3/11/2008

• ACADIA Pharmaceuticals, Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007

  3/6/2008

• ACADIA Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on March 5, 2008

  2/27/2008

• ACADIA Pharmaceuticals, Inc. Appoints John J. Kaiser as Vice President, Strategic Marketing and Commercial Development

  2/12/2008

• ACADIA Pharmaceuticals, Inc. Announces Presentation of Data on Pimavanserin Co-Therapy at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders

  2/5/2008

• ACADIA Pharmaceuticals, Inc. to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 12, 2008

  2/4/2008

• ACADIA Pharmaceuticals, Inc. to Present at the 26th Annual JP Morgan Healthcare Conference on January 7, 2008

  12/26/2007

• ACADIA Pharmaceuticals, Inc. Announces Completion of Enrollment of ACP-104 Phase IIb Clinical Trial Ahead of Schedule

  12/14/2007

• ACADIA Pharmaceuticals, Inc. to Webcast Its Analyst and Investor Meeting on December 14, 2007

  12/6/2007

• ACADIA Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

  11/7/2007

• ACADIA Pharmaceuticals, Inc. Reports Third Quarter 2007 Financial Results

  11/6/2007